Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	[1]	$ 563,142	$ 437,577
Accounts receivable	[1]	705,747	775,452
Inventories	[1]	108,231	105,485
Prepaid expenses	[1]	119,956	77,281
Other current assets	[1]	193,616	222,290
Total current assets	[1]	1,690,692	1,618,085
Assets, Noncurrent [Abstract]
Property and equipment, net	[1]	814,860	811,089
Goodwill	[1]	852,001	844,704
Other intangible assets, net	[1]	76,930	76,930
Deferred income taxes	[1]	34,764	32,491
Other assets	[1]	137,307	147,106
Total assets	[1]	4,800,014	4,731,558
Current liabilities:
Current installments of long-term debt	[1]	12,167	18,605
Accounts payable	[1]	368,850	474,543
Accrued salaries and benefits	[1]	255,370	267,685
Other accrued expenses and liabilities	[1]	250,945	233,271
Total current liabilities	[1]	887,332	994,104
Liabilities, Noncurrent [Abstract]
Long-term debt, less current maturities	[1]	1,083,725	1,168,253
Self-insured liabilities	[1]	231,951	243,552
Other long-term liabilities	[1]	53,686	76,002
Total liabilities	[1]	3,413,145	3,649,242
Commitments and contingencies	[1]
Equity:
Redeemable noncontrolling interests	[1]	2,391	7,302
Common units, no and unlimited units authorized as of September 30, 2024 and December 31, 2023, respectively; no and 484,922,828 units issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	[1]	0	496,882
Preferred stock, par value $0.01 per share; 50,000,000 and no shares authorized as of September 30, 2024 and December 31, 2023, respectively; no shares issued and outstanding as of September 30, 2024 and December 31, 2023	[1]	0	0
Common stock, par value $0.01 per share; 750,000,000 and no shares authorized as of September 30, 2024 and December 31, 2023, respectively; 142,735,842 and no shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	[1]	1,428	0
Additional paid-in capital	[1]	743,364	0
Accumulated other comprehensive income	[1]	9,486	18,561
Retained earnings	[1]	251,592	155,453
Equity attributable to Ardent Health Partners, Inc.	[1]	1,005,870	670,896
Noncontrolling interests	[1]	378,608	404,118
Total equity	[1]	1,384,478	1,075,014
Total liabilities and equity	[1]	4,800,014	4,731,558
Nonrelated Party
Assets, Noncurrent [Abstract]
Operating lease right of use assets	[1]	261,214	260,003
Liabilities, Noncurrent [Abstract]
Long-term operating lease liability	[1]	233,786	235,241
Related Party
Assets, Noncurrent [Abstract]
Operating lease right of use assets	[1]	932,246	941,150
Liabilities, Noncurrent [Abstract]
Long-term operating lease liability	[1]	$ 922,665	$ 932,090

[1] As of September 30, 2024 and December 31, 2023, the unaudited condensed consolidated balance sheets included total liabilities of consolidated variable interest entities of $303.2 million and $337.8 million, respectively. Refer to Note 2, Summary of Significant Accounting Policies, for further discussion.